Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients

被引:202
作者
Petrovics, G
Zhang, W
Makarem, M
Street, JP
Connelly, R
Sun, L
Sesterhenn, IA
Srikantan, V
Moul, JW
Srivastava, S
机构
[1] Uniformed Serv Univ Hlth Sci, Ctr Prostate Dis Res, Dept Surg, US Mil Canc Inst, Bethesda, MD 20814 USA
[2] Armed Forces Inst Pathol, Dept Genitourinary Pathol, Washington, DC 20306 USA
[3] Walter Reed Army Med Ctr, Serv Urol, Washington, DC 20307 USA
关键词
PCGEM1; prostate-specific gene; prostate cancer; high-risk patients; cell proliferation;
D O I
10.1038/sj.onc.1207069
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PCGEM1 is a novel, highly prostate tissue-specific, androgen-regulated gene. Here, we demonstrate that PCGEM1 expression is significantly higher in prostate cancer (CaP) cells of African-American men than in Caucasian-American men (P=0.0002). Further, increased PCGEM1 expression associates with normal prostate epithelial cells of CaP patients with a family history of CaP (P=0.0400). PCGEM1 overexpression in LNCaP and in NIH3T3 cells promotes cell proliferation and a dramatic increase in colony formation, suggesting a biological role of PCGEM1 in cell growth regulation. Taken together, the cell proliferation/colony formation-promoting functions of PCGEM1 and the association of its increased expression with high-risk CaP patients suggest the potential roles of PCGEM1 in CaP onset/progression, especially in these high-risk groups.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 34 条
  • [1] RETROVIRAL INSERTIONS IN THE MURINE HIS-1 LOCUS ACTIVATE THE EXPRESSION OF A NOVEL RNA THAT LACKS AN EXTENSIVE OPEN READING FRAME
    ASKEW, DS
    LI, J
    IHLE, JN
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 1743 - 1751
  • [2] Brantey MA, 2000, CANCER RES, V60, P4320
  • [3] Brawley O W, 1998, Semin Urol Oncol, V16, P193
  • [4] Bussemakers MJG, 1999, CANCER RES, V59, P5975
  • [5] Cussenot O, 2001, Eur J Intern Med, V12, P11, DOI 10.1016/S0953-6205(00)00136-9
  • [6] de Kok JB, 2002, CANCER RES, V62, P2695
  • [7] Delineation of prognostic biomarkers in prostate cancer
    Dhanasekaran, SM
    Barrette, TR
    Ghosh, D
    Shah, R
    Varambally, S
    Kurachi, K
    Pienta, KJ
    Rubin, MA
    Chinnaiyan, AM
    [J]. NATURE, 2001, 412 (6849) : 822 - 826
  • [8] Guo YP, 2000, PROSTATE, V42, P130, DOI 10.1002/(SICI)1097-0045(20000201)42:2<130::AID-PROS7>3.0.CO
  • [9] 2-3
  • [10] TUMOR-SUPPRESSOR ACTIVITY OF H19 RNA
    HAO, Y
    CRENSHAW, T
    MOULTON, T
    NEWCOMB, E
    TYCKO, B
    [J]. NATURE, 1993, 365 (6448) : 764 - 767